Keyphrases
25-hydroxyvitamin D (25OHD)
21%
Acute Inflammatory
13%
Adverse Drug Reaction
32%
Adverse Reactions
17%
Anemia
21%
Angiotensin Receptor Blockers
42%
Angiotensin-converting Enzyme
53%
Angiotensin-converting Enzyme Polymorphisms
24%
Cancer Patients
32%
Cognitive Impairment
21%
Confidence Interval
22%
Convenience Sampling
17%
COVID-19
36%
Defnition
21%
Drug Class
14%
Drug-related Problems
21%
Elderly Patients
21%
Emergency Department
14%
Enzyme Polymorphism
18%
Gastrointestinal
13%
Genetic Variation
21%
Genotype
35%
Genotype Frequency
15%
Google Scholar
13%
Hospital Admission
21%
Hospitalization
26%
Hospitalized Patients
28%
Hydroxychloroquine
17%
In Cancer
21%
Lima
31%
Meta-analysis
75%
Middle-aged
14%
No Significant Difference
19%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
26%
Nononcologic
13%
Old Age
16%
Older Adults
22%
Older People
58%
Operational Definition
26%
Overprescription
21%
Peru
21%
Peruvian
75%
Polymorphism
25%
Prognostic Factors
21%
PubMed
15%
Safety Aspects
17%
SARS-CoV-2 Infection
71%
Terminal Illness
18%
Vitamin D Status
23%
Young-old
14%
Pharmacology, Toxicology and Pharmaceutical Science
25 Hydroxyvitamin D
5%
Acetylsalicylic Acid
21%
Acute Heart Infarction
21%
Adverse Drug Reaction
53%
Adverse Event
38%
Alzheimer's Disease
10%
Angiotensin II Antagonist
10%
Angiotensin Receptor Antagonist
32%
Asthma
10%
Atrial Fibrillation
21%
Beta Adrenergic Receptor Blocking Agent
21%
Beta Adrenergic Receptor Stimulating Agent
10%
C Reactive Protein
10%
Cardiotoxicity
10%
Chloroquine
10%
Chronic Kidney Failure
7%
Clinical Pharmacology
5%
Comorbidity
5%
Coronavirinae
10%
Creatinine
10%
D Dimer
5%
Dipeptidyl Carboxypeptidase Inhibitor
10%
Disease
38%
Ferritin
5%
Hydroxychloroquine
19%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
10%
Infection
100%
Inflammation
20%
Interleukin 6
5%
Lactate Dehydrogenase
5%
Metformin
10%
Nephrotoxicity
7%
Non Insulin Dependent Diabetes Mellitus
11%
Non Prescription Drug
5%
Non-Steroidal Anti-Inflammatory Drug
26%
Observational Study
15%
Pandemic
5%
Pharmacodynamics
10%
Pharmacokinetics
10%
Polypharmacy
10%
Prevalence
11%
Proton Pump Inhibitor
10%
Random Effects Model
5%
Randomized Controlled Trial
8%
SARS Coronavirus
84%
Severe Acute Respiratory Syndrome
21%
Syndrome
10%
Terminal Illness
10%
Vitamin D
24%
Warfarin
21%
Medicine and Dentistry
ACE Inhibitor
10%
Anemia
21%
Angiotensin Receptor Antagonist
10%
Catastrophic Illness
13%
Cognitive Defect
23%
COVID-19
10%
Deterioration
5%
Diagnostic and Statistical Manual of Mental Disorders
5%
Diagnostic Test
5%
Disease
25%
DSM-IV
5%
Emergency Department
12%
Health Care Cost
10%
Hematologic Malignancy
12%
Infection
23%
Liver Toxicity
10%
Malignant Neoplasm
30%
Maturity Onset Diabetes of the Young
7%
Meta-Analysis
10%
Multivariate Analysis
7%
Overall Survival
6%
Prevalence
10%
Prognostic Factor
21%
Pyrazinamide
10%
Sensitivity and Specificity
5%
Serositis
6%
Severe Acute Respiratory Syndrome
10%
Severe Acute Respiratory Syndrome Coronavirus 2
27%
Solid Malignant Neoplasm
6%
Solid Tumor
6%
Symptomatic Treatment
12%
Systematic Review
12%
Terminal Illness
12%
Toxic Hepatitis
10%
Triage
10%
Vitamin D
10%
